Tag: paclitaxel
First-in-human results for dual-drug therapy DCB released
Advanced NanoTherapies has announced positive results from its first-in-human (FIH) trial evalua...
CX 2024: Paclitaxel device restrictions “did cause harm”
“Unfortunately, we are doing worse for our patients today,” were the sobering words of Eric Sece...
TCT 2023: First presentation of complete patient-level dataset on paclitaxel and death that helped sway the US FDA
Data from a patient-level meta-analysis—a factor in the US Food and Drug Administration’s (FDA) ...
SCAI welcomes FDA decision to remove red flag for use of paclitaxel-coated devices in PAD
The president of the Society for Cardiovascular Angiography & Interventions (SCAI), George D...
Timeline: Key milestones in the paclitaxel story
The release of a letter from the US Food and Drug Administration (FDA) concerning the use of paclita...
Boston Scientific announces position on FDA update about use of paclitaxel-coated devices to treat PAD
Following yesterday's news that the US Food and Drug Administration (FDA) has changed its stance on ...
Long-awaited US FDA update finds data do not support excess mortality risk for paclitaxel-coated devices
In a letter to healthcare providers dated 11 July 2023, the US Food and Drug Administration (FDA...
EuroPCR 2023: Biolimus-coated balloon fails to match paclitaxel for in-stent restenosis
Results of the first study of a first-generation drug-coated balloon (DCB) with a biolimus coati...
Society for Cardiovascular Angiography and Interventions supports continued use of paclitaxel devices
Experts from the Society for Cardiovascular Angiography and Interventions (SCAI) have reviewed the r...
Meta-analysis finds a higher risk of death in the long term when paclitaxel-coated devices are used in the leg
New data, just published in the Journal of the American Heart Association (JAHA), suggest that t...
